9999999997-18-005483.txt : 20180503 9999999997-18-005483.hdr.sgml : 20180503 20180503150826 ACCESSION NUMBER: 9999999997-18-005483 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 ACTION DATE: 20180503 RECEIVED DATE: 20180503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 18803374 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 5 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 36 94 44 86 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 5 CITY: HELLERUP STATE: G7 ZIP: DK-2900 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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